Home › NDC Lookup › RxCUI directory › RxCUI 2695445

Pilocarpine hydrochloride 4 MG/ML Ophthalmic Solution [Qlosi] — RxCUI 2695445

RxNorm drug concept · Semantic branded drug
RxCUI 2695445 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2695445
Official namePilocarpine hydrochloride 4 MG/ML Ophthalmic Solution [Qlosi]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asQlosi 0.4 % Ophthalmic Solution; Qlosi 4 MG/ML Ophthalmic Solution
FDA products mapped1
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pilocarpine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Eye drops are used for glaucoma, raised eye pressure or presbyopia, depending on the brand. Tablets treat dry mouth from head and neck radiation or Sjogr...
  • Eye drops go in the eye and tablets are swallowed. Schedules vary by product, so follow your prescriber and your label. For dry mouth, it can take weeks to know if the tablets are...
  • With tablets, sweating is the most common, along with nausea, runny nose, diarrhea and chills. Eye forms can blur your vision, especially at night. Call your doctor if effects are...
  • Use extra caution. Tablets should not be used with uncontrolled asthma. With controlled asthma, COPD, chronic bronchitis or significant heart disease, you would need close supervis...
📖 Read our full Pilocarpine guide →

🕸️ Concept Web — How Pilocarpine hydrochloride 4 MG/ML Ophthalmic Sol... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pilocarpine hydrochloride 4 MG/ML Ophthalmic Solution [Qlosi] RxCUI 2695445

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pilocarpine 8328
    • Pilocarpine hydrochloride 235426
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Qlosi 2695440
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pilocarpine Ophthalmic Solution 373454
    • Pilocarpine hydrochloride Ophthalmic Solution 2646497
    • Pilocarpine Ophthalmic Product 1158735
    • Pilocarpine hydrochloride Ophthalmic Product 2660246
    • Pilocarpine Ophthalmic Solution [Qlosi] 2695443
    • Pilocarpine hydrochloride Ophthalmic Solution [Qlosi] 2695444
    • Qlosi Ophthalmic Product 2695442
    • Ophthalmic Solution 7670
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pilocarpine hydrochloride 4 MG/ML Ophthalmic Solution SCD · 2695439
  • Pilocarpine hydrochloride 4 MG/ML SCDC · 2695438
  • Pilocarpine Ophthalmic Solution SCDF · 373454
  • Pilocarpine hydrochloride Ophthalmic Solution SCDFP · 2646497
  • Pilocarpine Ophthalmic Product SCDG · 1158735
  • Pilocarpine hydrochloride Ophthalmic Product SCDGP · 2660246

Brand-Name Concepts

  • Pilocarpine hydrochloride 4 MG/ML [Qlosi] SBDC · 2695441
  • Pilocarpine Ophthalmic Solution [Qlosi] SBDF · 2695443
  • Pilocarpine hydrochloride Ophthalmic Solution [Qlosi] SBDFP · 2695444
  • Qlosi Ophthalmic Product SBDG · 2695442
  • Qlosi BN · 2695440

📦 FDA Products & Package NDCs

1 product · 4 package NDCs
4 package NDCs map to RxCUI 2695445 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83661-0018-10 10 VIAL, SINGLE-USE in 1 BOX (83661-018-10) / .4 mL in 1 VI... Qlosi Orasis Pharmaceuticals, Inc. 2025-01-15
83661-0018-20 20 VIAL, SINGLE-USE in 1 BOX (83661-018-20) / .4 mL in 1 VI... Qlosi Orasis Pharmaceuticals, Inc. 2025-01-15
83661-0018-30 30 VIAL, SINGLE-USE in 1 BOX (83661-018-30) / .4 mL in 1 VI... Qlosi Orasis Pharmaceuticals, Inc. 2024-10-15
83661-0018-60 60 VIAL, SINGLE-USE in 1 BOX (83661-018-60) / .4 mL in 1 VI... Qlosi Orasis Pharmaceuticals, Inc. 2025-01-15
Observed labelers: Orasis Pharmaceuticals, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.